Our News on Newswise

Small Test Group Shows ALS Patients’ Own Cells May Provide a Safe Pathway to Slow or Halt Progression of the Deadly Degenerative Disease

Removing ALS (amyotrophic lateral sclerosis) patients’ own dysfunctional cells, fixing them, then putting them back in patients’ bodies is a safe, well tolerated process that has been shown to slow or halt disease progression in a small number...
5-Oct-2022 4:15 PM EDT Add to Favorites

Newswise: 633c3b19d3a3a_MITIEverseappimage.jpg

Houston Methodist enters the metaverse with launch of new MITIEverse™ app

Exploring the heart from the inside out is now possible with a new app from Houston Methodist.
4-Oct-2022 10:05 AM EDT Add to Favorites

Improving hospital stays and outcomes for older patients with dementia through AI

By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission. This early assessment of outcomes means more timely...
30-Sep-2022 4:30 PM EDT Add to Favorites

Taking aim at triple-negative breast cancer and multiple myeloma to improve prognoses

Two Houston Methodist cancer researchers have been awarded a half million dollars in funding from the Cancer Prevention and Research Institute of Texas (CPRIT) to further research two of the most lethal, difficult-to-treat cancers that...
30-Sep-2022 4:05 PM EDT Add to Favorites

Newswise: 63336f1162c15_HMflutracker9-26-22.jpg

Houston Methodist seeing December flu season peak numbers now

Texas already has a moderately high rate of flu cases in September. This doesn’t look good for flu season, which was uncharacteristically low last year because of masks and people isolating. Houston Methodist experts are encouraging the community...
27-Sep-2022 5:05 PM EDT Add to Favorites

Newswise: 62fd3294a1870_JACCLongCOVIDHeart.jpg

Reduced myocardial blood flow is new clue in how COVID-19 is impacting the heart

Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist. This finding offers a new clue in understanding...
17-Aug-2022 2:45 PM EDT Add to Favorites

A new way to control pain after knee replacement surgery

Houston Methodist researchers present clinical evidence supporting the safety and efficacy of injecting pain medication directly into the tibia during knee replacement surgery for better postoperative pain management. The study revealed patients...
12-Aug-2022 2:05 PM EDT Add to Favorites

Houston Methodist study finds new chronic rhinitis treatment could be game changer

A new study at Houston Methodist shows that that a new temperature-controlled radiofrequency intervention is a safe and effective way to improve symptoms of chronic rhinitis. Chronic rhinitis involves symptoms such as a near constant runny nose,...
4-Aug-2022 5:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: 63601dbf57734_BernickerEricDSC03056.jpg

Thoracic oncologist available on how climate change is impacting lung cancer rates and the effectiveness of immunotherapy

31-Oct-2022 3:15 PM EDT

Surgeons Remove Grapefruit-Sized Tumor From Man’s Brain; Implant 3D Computer Generated Prosthetic Skull Piece

Patient Chris DeHart had a massive meningioma that required 9 surgeries and 3 surgical specialties to remove. He relied on a Houston Methodist 'dream team' of surgeons to solve his case.
27-Oct-2022 3:30 PM EDT

Don’t lose sleep over daylight saving time

11-Mar-2022 1:30 PM EST

Houston Methodist experts on J&J vaccine announcement

24-Feb-2021 10:10 AM EST

Houston Methodist expert notes COVID-19 precautions lead to historic drop in flu cases

A silver lining is emerging amid the COVID-19 pandemic. Influenza numbers are way down – 98 percent down, according to the CDC. Locally, during flu season last year, Houston Methodist’s system of eight hospitals saw 250 to 450 flu cases per...
2-Feb-2021 2:30 PM EST

Principal Investigator for COVID-19 drug with FDA Emergency Use Authorization available to speak on limited government supply of drug and pending clinical trials

17-Nov-2020 1:05 PM EST

Newswise: 628d56db15ece_HeadshotCookeJohnDSC03713.jpg

Messenger RNA – the Therapy of the Future

16-Nov-2020 10:40 AM EST

Newswise: geyer-charles-1891795001.jpg

Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19

24-Jun-2020 10:10 AM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

U.S. News & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine’s biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey’s achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.

Experts

Contacts

Stefanie Asin
Public Relations Director
Corporate Communications

SLAsin@houstonmethodist.org

832-667-5809

Gale Smith
Public Relations Manager
Research Institute, Gastroenterology & GI Surgery, Ophthalmology, Otolaryngology/ENT

GSmith@houstonmethodist.org

832-667-5843

Lisa Merkl
Senior Research Media Relations Editor
Research Institute

lmerkl@houstonmethodist.org

832-667-5916

Ashley White
Public Relations Program Manager
Cancer Center, Heart & Vascular Center

aewhite2@houstonmethodist.org

832-667-5849

Patti Muck
Public Relations Program Manager
Neurological Institute, Emergency Medicine

pamuck@houstonmethodist.org

713.851.4596

Amy Rose
Senior Media Relations Specialist
Transplant Center, Orthopedics & Sports Medicine

akrose@houstonmethodist.org

Twitter

close
0.78279